Search clinical trials for: DP-R206

Total 383 results

1
2
3
4
5
6
7
8
›

Alvogen Korea

Completed

Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia (ROSE)

Primary Hypercholesterolemia

Korea, Republic of
Alvogen Korea

Completed

Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers

Healthy

Korea, Republic of
Alvogen Korea

Completed

Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed Conditions

Healthy

Korea, Republic of
Alvogen Korea

Completed

Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers

Healthy

Korea, Republic of
D-Pharm Ltd.

Withdrawn

DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study

Migraine

Israel
Alvogen Korea

Completed

Pharmacokinetic / Pharmacodynamic (PK/PD) Study of Multiple Doses of DP-R202 in Healthy Volunteers

Healthy

Korea, Republic of
Alvogen Korea

Completed

Safety and Pharmacokinetic Characteristics of DP-R206(Vitamin D3) in Healthy Adult Volunteers

Healthy

Korea, Republic of
AbbVie

Recruiting

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair

Ventral Hernia

United States
Neurolief Ltd.

Completed

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD) (MDD)

MDD

United States, Israel
Galderma R&D

Completed

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Glabellar Frown Lines | Canthal Lines

United States
Universidad de Extremadura

Completed

Textbook Outcome in Distal Pancreatectomy (TO-ERPANDIS)

Distal Pancreatectomy
ReNeuron Limited

Completed

Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia

Peripheral Arterial Disease

United Kingdom
D-Pharm Ltd.

Completed

Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke

Stroke | Cerebrovascular Disorders | Brain Ischemia

Israel, Germany
ReNeuron Limited

Completed

Pilot Investigation of Stem Cells in Stroke Phase II Efficacy (PISCES-II)

Cerebral Infarction | Hemiparesis | Ischaemic Stroke | Arm Paralysis

United Kingdom
Alvogen Korea

Completed

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy

Hypertension | Cholesterolemia

Korea, Republic of
Alberta Health services

Not yet recruiting

Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection

Pulmonary Disease | Bacteriophage Therapy | Mycobacterium Abscessus Infection
Fundación para la Investigación del Hospital Clínico...

Unknown

OLA to Lowest DP in Cardiac Surgery

Lung Collapse

Spain
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Arterial dP/dt Dependency on Loading Conditions (REABILITY)

Intraoperative Hemodyamic Monitoring

Italy
Laboratorios Leti, S.L.

Completed

Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma

Asthma | Rhinitis | Rhinoconjunctivitis

Spain
Factor Therapeutics Ltd.
Parexel; ARANZ Medical; Almac Clinical Services LLC

Unknown

Study of VF001-DP in Patients With Chronic Venous Leg Ulcers

Pathologic Processes | Cardiovascular Diseases | Vascular Diseases | Skin Diseases | Ulcer | Leg Ulcer | Skin Ulcer | Varicose Ulcer

United States
University Hospital, Grenoble

Unknown

Electronic Pharmaceutical Record Used for Medication Reconciliation by a Pharmacist Associated to the Anesthesiologist Consultation (DP-CONCIL)

Electronic Health Records

France
Seoul National University Hospital

Completed

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents (Grand-DES)

Coronary Artery Disease

South Korea
Medtronic Cardiac Rhythm and Heart Failure
Medtronic

Completed

Cardiac Resynchronization Therapy (CRT)-Narrow-dp/Dt-Study (CRT-Narrow)

Heart Failure

Germany
Breath of Life International Pharma Ltd

Withdrawn

A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome.

Endometriosis
Cyprus University of Technology

Unknown

Management of my Bipolarity Intervention in Bipolar Disorder Patients (MoB)

Bipolar Disorder | Depression, Bipolar | Affective Psychosis, Bipolar | Manic-Depressive Psychosis

Cyprus
Antev Ltd.

Not yet recruiting

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

GnRH Antagonist | Advanced Prostate Cancer
University Hospital, Clermont-Ferrand
Pôle Santé République; Service de Néphrologie et Hémodialyse; Jacques Lacarin...

Unknown

Measurement of the Energy Metabolism of Peritoneal Dialysis Patients (CALIMERO 2)

Renal Failure

France
Alvogen Korea

Withdrawn

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

Hypertension | Hypercholesterolemia
Philipps University Marburg Medical Center

Completed

Components of Placebo Effects in Sadness (COPES)

Dysphoric Mood

Germany
Breath of Life International Pharma Ltd

Withdrawn

BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus
Breath of Life International Pharma Ltd

Terminated

Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

Diabetic Neuropathy

Israel
Bristol-Myers Squibb

Completed

Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis

Scleroderma, Diffuse

United States
Rise Therapeutics LLC

Recruiting

R-2487 in Patients With Rheumatoid Arthritis (R-2487-RA01)

Arthritis, Rheumatoid

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Withdrawn

Discomfort Perceived by a Cohort of Patients Treated With Aligners and Attachments Placed According to Two Different Protocols (ATTACH-1)

Malocclusion

Italy
Suzhou Abogen Biosciences Co., Ltd.

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)

COVID-19

United Arab Emirates
Daiichi Sankyo
Merck Sharp & Dohme LLC

Active, not recruiting

U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

United States, Spain, Netherlands, Taiwan, Japan, South Korea
Galderma R&D

Completed

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States
Breath of Life International Pharma Ltd

Completed

BOL-DP-o-04 in Patients With Low Back Pain and Sciatica

Low Back Pain | Sciatica

Israel
GenSight Biologics

Active, not recruiting

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa (PIONEER)

Non-syndromic Retinitis Pigmentosa

United States, France, United Kingdom
Qurgen Inc.

Recruiting

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Solid Tumor

United States
Alvogen Korea

Completed

A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone

Healthy Volunteers
Suzhou Abogen Biosciences Co., Ltd.

Active, not recruiting

A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines

COVID-19

Indonesia
Grant Dorsey, M.D, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID); Karolinska Institutet and other collaborators

Active, not recruiting

Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP) (MIC-DroP)

Malaria

Uganda
Qurgen Inc.

Recruiting

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Gastric Cancer | Solid Tumor | Liver Cancer

China
Anhui Provincial Hospital

Recruiting

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

B Lymphoblastic Leukemia/Lymphoma

China
Janssen Vaccines & Prevention B.V.
National Institute of Allergy and Infectious Diseases (NIAID); Beth Israel... and other collaborators

Completed

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

Healthy

United States, South Africa, Thailand, Uganda, Rwanda
Alvogen Korea

Completed

Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease (DAVICI)

Peripheral Arterial Disease
Chinese University of Hong Kong

Completed

MK-2206 in Recurrent Nasopharyngeal Carcinoma (MC1079)

Recurrent Nasopharyngeal Carcinoma

Hong Kong
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital; University... and other collaborators

Withdrawn

MK-2206 for Recurrent Malignant Glioma

Malignant Glioma

United States
AgonOx, Inc.
Providence St Joseph Health; Phio Pharmaceuticals Inc.

Active, not recruiting

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors (ACT)

Melanoma | Gynecologic Cancer | Colorectal Cancer | Lung Cancer | HNSCC | Urogenital Cancer

United States

1
2
3
4
5
6
7
8
›

Subscribe